FDA plans fast approvals for Omicron-targeting vaccines
November 30, 2021Manufacturing and Production
Joe Biden has directed the FDA and CDC to respond quickly to applications for vaccines or boosters to shield against …
NICE recommends Tagrisso (osimertinib) in England for lung cancer patients
November 30, 2021Manufacturing and Production
AstraZeneca have announced that Tagrisso (osimertinib) is now available as an adjuvant treatment option to patients in England with completely …
Vaccine makers pledge to develop Omicron-effective jab
November 29, 2021Sales and Marketing
Leading vaccine producers have shared that they are already pursuing vaccine responses to the newly-discovered coronavirus variant, Omicron. BioNTech has …
Nottinghamshire school sets up targeted testing for Omicron
November 29, 2021Sales and Marketing
A school in Nottingham has set up targeted testing after a case of the new COVID-19 variant, Omicron, was detected …
WHO: unclear if Omicron causes severe disease
November 29, 2021Sales and Marketing
WHO has shared that it is still unclear whether the recently-detected coronavirus variant Omicron is more transmissible, or causes more …
FDA approves AI-based breast cancer screening software MammoScreen®
November 29, 2021Sales and Marketing
The FDA has approved MammoScreen®, Therapixel’s explainable and actionable Artificial Intelligence (AI) based software assisting Radiologists in breast cancer screening. …
New COVID-19 variant in South Africa as massive surge in Europe infections
November 26, 2021Medical Communications
A new variant of coronavirus found in South Africa is feared to be more transmissible than other strains, and poses …
Allorion gains $40 million funding to enhance and discover precision targets
November 26, 2021Medical Communications
Allorion Therapeutics has announced that they have gained $40 million in Series A financing. The funding was led by Chinese …
US government expands COVID-19 booster eligibility ahead of holidays
November 25, 2021Business Services
The Biden administration has expanded COVID-19 booster eligibility, and millions of Americans have received their booster shots at a near …
Groundbreaking success shown in target drug combination for aggressive brain tumours
November 25, 2021Business Services
A combination of two targeted cancer drugs have shown unprecedented activity in patients with highly malignant brain tumours carrying a …
FDA approve first therapy to treat ultra-rare cancer
November 24, 2021Research and Development
Aadi Bioscience announced that the FDA have approved the intravenous drug Fyarro (sirolimus protein-bound particles for injectable suspension) for the …
Ocuphire announces beginning of Phase III trial of treatment for reversal of mydriasis (RM)
November 24, 2021Research and Development
Ocuphire Pharma, a clinical-stage ophthalmic biopharmaceutical company, announced that the first subjects have been enrolled in the MIRA-3 Phase III …
FDA approves Livtencity as first treatment for drug-resistant post-transplant infection
November 24, 2021Manufacturing and Production, Research and Development
The FDA have approved Livtencity (maribavir) as the first drug for treating adults and pediatric patients with a common type …
HUTCHMED and AstraZeneca begin Phase III trial of lung cancer treatment
November 24, 2021Research and Development
HUTCHMED Limited and AstraZeneca have initiated SACHI, a China Phase III study of Savolitinib (ORPATHYS®), an oral, potent, and highly …
Santhera and ReveraGen announce positive results from VISION-DMD study
November 23, 2021Manufacturing and Production
Santhera Pharmaceuticals and ReveraGen BioPharma have announced new topline results after completion of the VISION-DMD study at week 48.
Sterling Pharma Solutions announces £10m investment to increase manufacturing capacity
November 23, 2021Manufacturing and Production
Contract development and manufacturing organisation Sterling Pharma Solutions has announced a £10m multi-year investment strategy for its site in Dudley, …
European Commission approves BYANNLI for management of schizophrenia in adults
November 23, 2021Manufacturing and Production
Johnson & Johnson have announced the approval of the long-acting atypical antipsychotic therapy BYANNLI® by the European Commission (EC), for …
Breakthrough personalised T-cell therapy for children with brain tumours
November 23, 2021Manufacturing and Production
The Centre for Cancer and Immunology Research, Children’s National Research Institute, have developed a new approach that identifies unique proteins …
FDA approves Pfizer and Moderna boosters for all US adults
November 22, 2021Sales and Marketing
The FDA and CDC have cleared the Pfizer and Moderna booster jabs for adults, after reviewing new data supporting the …
FDA accept New Drug Application for Obseva’s linzagolix
November 22, 2021Sales and Marketing
Obseva, a biopharmaceutical company developing and commercialising novel therapies to improve reproductive health, have announced that the NDA for linzagolix …
Latest content
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
Danish medical cannabis use rises as regulator reports no new safety signals
